Lifu Sheng

1.1k total citations
11 papers, 635 citations indexed

About

Lifu Sheng is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Lifu Sheng has authored 11 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Neurology and 4 papers in Neurology. Recurrent topics in Lifu Sheng's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Ion channel regulation and function (3 papers). Lifu Sheng is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Ion channel regulation and function (3 papers). Lifu Sheng collaborates with scholars based in China, United States and Australia. Lifu Sheng's co-authors include Min Shi, Tessandra Stewart, Jing Zhang, Iryna Leshchyns’ka, Vladimir Sytnyk, Cyrus P. Zabetian, Na Li, Junichi Matsumoto, William A. Banks and Kristin M. Bullock and has published in prestigious journals such as Journal of Neuroscience, Neurology and Journal of Neurochemistry.

In The Last Decade

Lifu Sheng

11 papers receiving 631 citations

Peers

Lifu Sheng
Comparison fields: 5 of 79
  • Molecular Biology 377
  • Neurology 170
  • Neurology 146
  • Cancer Research 122
  • Cellular and Molecular Neuroscience 116
Travis J. Cook United States
Marco Barbariga Italy
Mac Robinson United States
Wiebke Moebius Germany
Sida Han China
Sabrina M. Heman-Ackah United States
Patrick Aro United States
Sudad Saman United States
Anita Ramanathan United States
Elena Abati Italy
Travis J. Cook United States View profile →
Citations per field, relative to Lifu Sheng
Lifu Sheng · 1×
Citations per year, relative to Lifu Sheng
Lifu Sheng · 1×

Countries citing papers authored by Lifu Sheng

Since Specialization
Citations

This map shows the geographic impact of Lifu Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifu Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifu Sheng more than expected).

Fields of papers citing papers by Lifu Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifu Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifu Sheng. The network helps show where Lifu Sheng may publish in the future.

Co-authorship network of co-authors of Lifu Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lifu Sheng. A scholar is included among the top collaborators of Lifu Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifu Sheng. Lifu Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
# Title Journal Authors Indexed citations
1 GV ‐971 attenuates α‐Synuclein aggregation and related pathology CNS Neuroscience & Therapeutics Zhenwei Yu, Ying Yang et al. 10
2 Erythrocytic α‐Synuclein and the Gut Microbiome: Kindling of the Gut‐Brain Axis in Parkinson's Disease Movement Disorders Ying Yang, Tessandra Stewart et al. 22
3 Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein–Containing Extracellular Vesicles Neurology Zhen Hong, Chen Tian et al. 21
4 Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis Acta Neuropathologica Communications Lifu Sheng, Tessandra Stewart et al. 42
5 Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein Journal of Neuroinflammation Na Li, Tessandra Stewart et al. 28
6 New windows into the brain: Central nervous system-derived extracellular vesicles in blood Progress in Neurobiology Min Shi, Lifu Sheng et al. 134
7 Neural Cell Adhesion Molecule 2 (NCAM2)-Induced c-Src-Dependent Propagation of Submembrane Ca2+ Spikes Along Dendrites Inhibits Synapse Maturation Cerebral Cortex Lifu Sheng, Iryna Leshchyns’ka et al. 19
8 Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases Journal of Neurochemistry Tessandra Stewart, Min Shi et al. 40
9 Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease? Acta Neuropathologica Communications Junichi Matsumoto, Tessandra Stewart et al. 214
10 Neural Cell Adhesion Molecule 2 Promotes the Formation of Filopodia and Neurite Branching by Inducing Submembrane Increases in Ca2+Levels Journal of Neuroscience Lifu Sheng, Iryna Leshchyns’ka et al. 43
11 Cell adhesion and intracellular calcium signaling in neurons Cell Communication and Signaling Lifu Sheng, Iryna Leshchyns’ka et al. 62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026